METHODS RELATING TO DISRUPTING THE BINDING OF AF9 PARTNER PROTEINS TO AF9 AND/OR ENL

摘要

The present invention relates to inhibitorsof AF9 and/or ENL, or DOT1L. The invention relates to the use of AF9 and/or ENL inhibitors for use in a method of treating an individual having cancer. In particular, the invention relates to a method of treating an individual having cancer, wherein the cancer has a mutation in KRAS; and wherein the cancer is a non-haematological cancer.